Retinal glial cell response in a neurodevelopmental disease such as the Dravet syndrome

José A. Fernández‐Albarral
DOI: https://doi.org/10.1111/aos.16346
2024-01-01
Acta Ophthalmologica
Abstract:Dravet syndrome (DS) is an epileptic encephalopathy caused by mutations in the Scn1a gene encoding the α1 subunit of the Nav1.1 sodium channel, which is associated with recurrent and generalized seizures, highly resistant to antiepileptic drugs, which is related to cognitive impairment, developmental delays, hyperactivity, dysautonomia, attention deficit, language impairment, autistic features, even leading to death. GABAergic interneurons are particularly affected, where the Nav1.1 channel is mainly located and the consequent imbalance between excitation and inhibition triggers brain hyperexcitability and seizures, altering the correct functioning of neural networks involved in cognitive processes. Glial reactivity and neuroinflammatory processes have been shown to be present in childhood epileptic processes and therefore cytokines may exert a neuromodulatory role directly impacting neuronal excitability. Indeed, astrocytes have been documented to be involved in the pathogenesis of epilepsy, regulating neurotransmitter and ion concentrations. In our experimental model of DS (Syn‐Cre/Scn1aWT/A1783V), inflammatory events in the prefrontal cortex and dentate gyrus of the hippocampus expressed as an increase in GFAP (astrocyte marker) and Iba‐1 (microglia marker) immunoreactivity have been observed, in addition to morphological changes compatible with activated astrocytes and microglia. The retina is a projection of the brain, and in several pathologies affecting the central nervous system, such as neurodegenerative diseases, correlation between changes occurring in the brain and those occurring in the retina has been shown. Therefore, the analyse of the changes that may occur in retinal glial cells (astrocytes and microglia) in an experimental model of DS, and the correlation with the alterations observed in some specific cerebral areas of these animals could be good predictive and prognostic biomarkers for future treatment. This study analyzes the retinal histological changes in glial cells (microglia and astrocytes), retinal ganglion cells (RGCs) and GABAergic amacrine cells in an experimental model of DS (Syn‐Cre/Scn1aWT/A1783V) compared to a control group at postnatal day (PND) 25. Retinal whole‐mounts were labelled with anti‐GFAP, anti‐Iba‐1, anti‐Brn3a and anti‐GAD65/67. Signs of microglial and astroglial activation and the number of Brn3a+ and GAD65+ 67+ cells were quantified. We found retinal activation of astroglial and microglial cells but not death of RGCs and GABAergic amacrine cells. These changes are similar to those found at the level of the hippocampus in the same experimental model in PND25, indicating a relationship between brain and retinal changes in DS. This suggests that the retina could serve as a possible biomarker in DS.
ophthalmology
What problem does this paper attempt to address?